Inotiv Inc (NOTV)
2.00
+0.02
(+1.01%)
USD |
NASDAQ |
May 24, 16:00
1.99
-0.01
(-0.50%)
After-Hours: 20:00
Inotiv Cash from Operations (Quarterly): 16.92M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.92M |
December 31, 2023 | -6.545M |
September 30, 2023 | 18.76M |
June 30, 2023 | 3.694M |
March 31, 2023 | 12.84M |
December 31, 2022 | -7.41M |
September 30, 2022 | 0.171M |
June 30, 2022 | -9.415M |
March 31, 2022 | 5.17M |
December 31, 2021 | -1.143M |
September 30, 2021 | 2.697M |
June 30, 2021 | 3.523M |
March 31, 2021 | 2.874M |
December 31, 2020 | 1.652M |
September 30, 2020 | -0.296M |
June 30, 2020 | 1.24M |
March 31, 2020 | -1.106M |
December 31, 2019 | 1.452M |
September 30, 2019 | 0.21M |
June 30, 2019 | 0.656M |
March 31, 2019 | 0.004M |
December 31, 2018 | 0.907M |
September 30, 2018 | 1.277M |
June 30, 2018 | 1.368M |
March 31, 2018 | 0.082M |
Date | Value |
---|---|
December 31, 2017 | 0.76M |
September 30, 2017 | -0.014M |
June 30, 2017 | 0.689M |
March 31, 2017 | -0.448M |
December 31, 2016 | 1.009M |
September 30, 2016 | 0.79M |
June 30, 2016 | 0.144M |
March 31, 2016 | 0.474M |
December 31, 2015 | -0.348M |
September 30, 2015 | 0.929M |
June 30, 2015 | 0.735M |
March 31, 2015 | 0.601M |
December 31, 2014 | -0.161M |
September 30, 2014 | 0.469M |
June 30, 2014 | 0.21M |
March 31, 2014 | -0.031M |
December 31, 2013 | 1.036M |
September 30, 2013 | 0.176M |
June 30, 2013 | 0.915M |
March 31, 2013 | -0.214M |
December 31, 2012 | 0.717M |
September 30, 2012 | 0.237M |
June 30, 2012 | -0.076M |
March 31, 2012 | -0.951M |
December 31, 2011 | 0.59M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.415M
Minimum
Jun 2022
18.76M
Maximum
Sep 2023
2.297M
Average
1.346M
Median
Cash from Operations (Quarterly) Benchmarks
Biolase Inc | -5.938M |
Akoya Biosciences Inc | -20.82M |
Durect Corp | -6.766M |
Macrogenics Inc | -45.64M |
Candel Therapeutics Inc | -8.438M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -4.587M |
Cash from Financing (Quarterly) | -1.173M |
Free Cash Flow | 9.573M |
Free Cash Flow Per Share (Quarterly) | 0.3831 |
Free Cash Flow to Equity (Quarterly) | 8.605M |
Free Cash Flow to Firm (Quarterly) | 19.69M |
Free Cash Flow Yield | 18.57% |